norethindrone has been researched along with Hyperparathyroidism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatterton, B; Horowitz, M; Need, A; Nordin, BE; Wishart, J | 1 |
| Peacock, M; Selby, PL | 1 |
| Horowitz, M; Morris, H; Need, AG; Nordin, BE; Philcox, J; Wishart, J | 1 |
3 other study(ies) available for norethindrone and Hyperparathyroidism
| Article | Year |
|---|---|
Treatment of postmenopausal hyperparathyroidism with norethindrone. Long-term effects on forearm mineral content.
Topics: Absorptiometry, Photon; Bone Density; Female; Humans; Hyperparathyroidism; Menopause; Middle Aged; Norethindrone; Radionuclide Imaging; Radius; Time Factors; Ulna | 1990 |
Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.
Topics: Bone Resorption; Calcitriol; Calcium; Ethinyl Estradiol; Female; Humans; Hydroxyproline; Hyperparathyroidism; Menopause; Middle Aged; Norethindrone; Parathyroid Hormone; Time Factors; Vitamin D-Binding Protein | 1986 |
Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
Topics: Aged; Bone and Bones; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hyperparathyroidism; Menopause; Middle Aged; Minerals; Norethindrone; Parathyroid Hormone; Phosphates | 1987 |